Global Prostate-specific Antigen (PSA) Testing Market Research Report 2023

Report ID: 1875858 | Published Date: Oct 2024 | No. of Page: 97 | Base Year: 2023 | Rating: 3.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Prostate-specific Antigen (PSA) Testing Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 CLIA Method
        1.2.3 ELISA Method
    1.3 Market by Application
        1.3.1 Global Prostate-specific Antigen (PSA) Testing Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Screening
        1.3.3 Post-treatment Monitoring
        1.3.4 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Prostate-specific Antigen (PSA) Testing Market Perspective (2017-2028)
    2.2 Prostate-specific Antigen (PSA) Testing Growth Trends by Region
        2.2.1 Prostate-specific Antigen (PSA) Testing Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Prostate-specific Antigen (PSA) Testing Historic Market Size by Region (2017-2022)
        2.2.3 Prostate-specific Antigen (PSA) Testing Forecasted Market Size by Region (2023-2028)
    2.3 Prostate-specific Antigen (PSA) Testing Market Dynamics
        2.3.1 Prostate-specific Antigen (PSA) Testing Industry Trends
        2.3.2 Prostate-specific Antigen (PSA) Testing Market Drivers
        2.3.3 Prostate-specific Antigen (PSA) Testing Market Challenges
        2.3.4 Prostate-specific Antigen (PSA) Testing Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Prostate-specific Antigen (PSA) Testing Players by Revenue
        3.1.1 Global Top Prostate-specific Antigen (PSA) Testing Players by Revenue (2017-2022)
        3.1.2 Global Prostate-specific Antigen (PSA) Testing Revenue Market Share by Players (2017-2022)
    3.2 Global Prostate-specific Antigen (PSA) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Prostate-specific Antigen (PSA) Testing Revenue
    3.4 Global Prostate-specific Antigen (PSA) Testing Market Concentration Ratio
        3.4.1 Global Prostate-specific Antigen (PSA) Testing Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Prostate-specific Antigen (PSA) Testing Revenue in 2021
    3.5 Prostate-specific Antigen (PSA) Testing Key Players Head office and Area Served
    3.6 Key Players Prostate-specific Antigen (PSA) Testing Product Solution and Service
    3.7 Date of Enter into Prostate-specific Antigen (PSA) Testing Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Prostate-specific Antigen (PSA) Testing Breakdown Data by Type
    4.1 Global Prostate-specific Antigen (PSA) Testing Historic Market Size by Type (2017-2022)
    4.2 Global Prostate-specific Antigen (PSA) Testing Forecasted Market Size by Type (2023-2028)
5 Prostate-specific Antigen (PSA) Testing Breakdown Data by Application
    5.1 Global Prostate-specific Antigen (PSA) Testing Historic Market Size by Application (2017-2022)
    5.2 Global Prostate-specific Antigen (PSA) Testing Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Prostate-specific Antigen (PSA) Testing Market Size (2017-2028)
    6.2 North America Prostate-specific Antigen (PSA) Testing Market Size by Country (2017-2022)
    6.3 North America Prostate-specific Antigen (PSA) Testing Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Prostate-specific Antigen (PSA) Testing Market Size (2017-2028)
    7.2 Europe Prostate-specific Antigen (PSA) Testing Market Size by Country (2017-2022)
    7.3 Europe Prostate-specific Antigen (PSA) Testing Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Size (2017-2028)
    8.2 Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Size by Country (2017-2022)
    8.3 Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Prostate-specific Antigen (PSA) Testing Market Size (2017-2028)
    9.2 Latin America Prostate-specific Antigen (PSA) Testing Market Size by Country (2017-2022)
    9.3 Latin America Prostate-specific Antigen (PSA) Testing Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size (2017-2028)
    10.2 Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size by Country (2017-2022)
    10.3 Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Abbott
        11.1.1 Abbott Company Detail
        11.1.2 Abbott Business Overview
        11.1.3 Abbott Prostate-specific Antigen (PSA) Testing Introduction
        11.1.4 Abbott Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
        11.1.5 Abbott Recent Development
    11.2 Boston Scientific Corporation
        11.2.1 Boston Scientific Corporation Company Detail
        11.2.2 Boston Scientific Corporation Business Overview
        11.2.3 Boston Scientific Corporation Prostate-specific Antigen (PSA) Testing Introduction
        11.2.4 Boston Scientific Corporation Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
        11.2.5 Boston Scientific Corporation Recent Development
    11.3 Bayer AG
        11.3.1 Bayer AG Company Detail
        11.3.2 Bayer AG Business Overview
        11.3.3 Bayer AG Prostate-specific Antigen (PSA) Testing Introduction
        11.3.4 Bayer AG Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
        11.3.5 Bayer AG Recent Development
    11.4 Siemens Healthcare
        11.4.1 Siemens Healthcare Company Detail
        11.4.2 Siemens Healthcare Business Overview
        11.4.3 Siemens Healthcare Prostate-specific Antigen (PSA) Testing Introduction
        11.4.4 Siemens Healthcare Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
        11.4.5 Siemens Healthcare Recent Development
    11.5 DiaSorin
        11.5.1 DiaSorin Company Detail
        11.5.2 DiaSorin Business Overview
        11.5.3 DiaSorin Prostate-specific Antigen (PSA) Testing Introduction
        11.5.4 DiaSorin Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
        11.5.5 DiaSorin Recent Development
    11.6 Roche
        11.6.1 Roche Company Detail
        11.6.2 Roche Business Overview
        11.6.3 Roche Prostate-specific Antigen (PSA) Testing Introduction
        11.6.4 Roche Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
        11.6.5 Roche Recent Development
    11.7 Beckman Coulter
        11.7.1 Beckman Coulter Company Detail
        11.7.2 Beckman Coulter Business Overview
        11.7.3 Beckman Coulter Prostate-specific Antigen (PSA) Testing Introduction
        11.7.4 Beckman Coulter Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
        11.7.5 Beckman Coulter Recent Development
    11.8 PerkinElmer
        11.8.1 PerkinElmer Company Detail
        11.8.2 PerkinElmer Business Overview
        11.8.3 PerkinElmer Prostate-specific Antigen (PSA) Testing Introduction
        11.8.4 PerkinElmer Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
        11.8.5 PerkinElmer Recent Development
    11.9 Tosoh
        11.9.1 Tosoh Company Detail
        11.9.2 Tosoh Business Overview
        11.9.3 Tosoh Prostate-specific Antigen (PSA) Testing Introduction
        11.9.4 Tosoh Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
        11.9.5 Tosoh Recent Development
    11.10 Ortho Clinical
        11.10.1 Ortho Clinical Company Detail
        11.10.2 Ortho Clinical Business Overview
        11.10.3 Ortho Clinical Prostate-specific Antigen (PSA) Testing Introduction
        11.10.4 Ortho Clinical Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
        11.10.5 Ortho Clinical Recent Development
    11.11 Fujirebio
        11.11.1 Fujirebio Company Detail
        11.11.2 Fujirebio Business Overview
        11.11.3 Fujirebio Prostate-specific Antigen (PSA) Testing Introduction
        11.11.4 Fujirebio Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
        11.11.5 Fujirebio Recent Development
    11.12 Mediwatch
        11.12.1 Mediwatch Company Detail
        11.12.2 Mediwatch Business Overview
        11.12.3 Mediwatch Prostate-specific Antigen (PSA) Testing Introduction
        11.12.4 Mediwatch Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
        11.12.5 Mediwatch Recent Development
    11.13 BodiTech
        11.13.1 BodiTech Company Detail
        11.13.2 BodiTech Business Overview
        11.13.3 BodiTech Prostate-specific Antigen (PSA) Testing Introduction
        11.13.4 BodiTech Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
        11.13.5 BodiTech Recent Development
    11.14 Bristol-Myers Squibb Company
        11.14.1 Bristol-Myers Squibb Company Company Detail
        11.14.2 Bristol-Myers Squibb Company Business Overview
        11.14.3 Bristol-Myers Squibb Company Prostate-specific Antigen (PSA) Testing Introduction
        11.14.4 Bristol-Myers Squibb Company Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
        11.14.5 Bristol-Myers Squibb Company Recent Development
    11.15 GE Healthcare
        11.15.1 GE Healthcare Company Detail
        11.15.2 GE Healthcare Business Overview
        11.15.3 GE Healthcare Prostate-specific Antigen (PSA) Testing Introduction
        11.15.4 GE Healthcare Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
        11.15.5 GE Healthcare Recent Development
    11.16 Endocare
        11.16.1 Endocare Company Detail
        11.16.2 Endocare Business Overview
        11.16.3 Endocare Prostate-specific Antigen (PSA) Testing Introduction
        11.16.4 Endocare Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
        11.16.5 Endocare Recent Development
    11.17 Merck＆Co.
        11.17.1 Merck＆Co. Company Detail
        11.17.2 Merck＆Co. Business Overview
        11.17.3 Merck＆Co. Prostate-specific Antigen (PSA) Testing Introduction
        11.17.4 Merck＆Co. Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
        11.17.5 Merck＆Co. Recent Development
    11.18 Medtronic
        11.18.1 Medtronic Company Detail
        11.18.2 Medtronic Business Overview
        11.18.3 Medtronic Prostate-specific Antigen (PSA) Testing Introduction
        11.18.4 Medtronic Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
        11.18.5 Medtronic Recent Development
    11.19 Sanofi-Aventis SA
        11.19.1 Sanofi-Aventis SA Company Detail
        11.19.2 Sanofi-Aventis SA Business Overview
        11.19.3 Sanofi-Aventis SA Prostate-specific Antigen (PSA) Testing Introduction
        11.19.4 Sanofi-Aventis SA Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
        11.19.5 Sanofi-Aventis SA Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Prostate-specific Antigen (PSA) Testing Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of CLIA Method
    Table 3. Key Players of ELISA Method
    Table 4. Global Prostate-specific Antigen (PSA) Testing Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 5. Global Prostate-specific Antigen (PSA) Testing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Prostate-specific Antigen (PSA) Testing Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Prostate-specific Antigen (PSA) Testing Market Share by Region (2017-2022)
    Table 8. Global Prostate-specific Antigen (PSA) Testing Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Prostate-specific Antigen (PSA) Testing Market Share by Region (2023-2028)
    Table 10. Prostate-specific Antigen (PSA) Testing Market Trends
    Table 11. Prostate-specific Antigen (PSA) Testing Market Drivers
    Table 12. Prostate-specific Antigen (PSA) Testing Market Challenges
    Table 13. Prostate-specific Antigen (PSA) Testing Market Restraints
    Table 14. Global Prostate-specific Antigen (PSA) Testing Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Prostate-specific Antigen (PSA) Testing Market Share by Players (2017-2022)
    Table 16. Global Top Prostate-specific Antigen (PSA) Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate-specific Antigen (PSA) Testing as of 2021)
    Table 17. Ranking of Global Top Prostate-specific Antigen (PSA) Testing Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Prostate-specific Antigen (PSA) Testing Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Prostate-specific Antigen (PSA) Testing Product Solution and Service
    Table 21. Date of Enter into Prostate-specific Antigen (PSA) Testing Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Prostate-specific Antigen (PSA) Testing Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Prostate-specific Antigen (PSA) Testing Revenue Market Share by Type (2017-2022)
    Table 25. Global Prostate-specific Antigen (PSA) Testing Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Prostate-specific Antigen (PSA) Testing Revenue Market Share by Type (2023-2028)
    Table 27. Global Prostate-specific Antigen (PSA) Testing Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Prostate-specific Antigen (PSA) Testing Revenue Market Share by Application (2017-2022)
    Table 29. Global Prostate-specific Antigen (PSA) Testing Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Prostate-specific Antigen (PSA) Testing Revenue Market Share by Application (2023-2028)
    Table 31. North America Prostate-specific Antigen (PSA) Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 32. North America Prostate-specific Antigen (PSA) Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 33. Europe Prostate-specific Antigen (PSA) Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 34. Europe Prostate-specific Antigen (PSA) Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Size by Region (2017-2022) & (US$ Million)
    Table 36. Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Size by Region (2023-2028) & (US$ Million)
    Table 37. Latin America Prostate-specific Antigen (PSA) Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Latin America Prostate-specific Antigen (PSA) Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Abbott Company Detail
    Table 42. Abbott Business Overview
    Table 43. Abbott Prostate-specific Antigen (PSA) Testing Product
    Table 44. Abbott Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
    Table 45. Abbott Recent Development
    Table 46. Boston Scientific Corporation Company Detail
    Table 47. Boston Scientific Corporation Business Overview
    Table 48. Boston Scientific Corporation Prostate-specific Antigen (PSA) Testing Product
    Table 49. Boston Scientific Corporation Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
    Table 50. Boston Scientific Corporation Recent Development
    Table 51. Bayer AG Company Detail
    Table 52. Bayer AG Business Overview
    Table 53. Bayer AG Prostate-specific Antigen (PSA) Testing Product
    Table 54. Bayer AG Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
    Table 55. Bayer AG Recent Development
    Table 56. Siemens Healthcare Company Detail
    Table 57. Siemens Healthcare Business Overview
    Table 58. Siemens Healthcare Prostate-specific Antigen (PSA) Testing Product
    Table 59. Siemens Healthcare Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
    Table 60. Siemens Healthcare Recent Development
    Table 61. DiaSorin Company Detail
    Table 62. DiaSorin Business Overview
    Table 63. DiaSorin Prostate-specific Antigen (PSA) Testing Product
    Table 64. DiaSorin Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
    Table 65. DiaSorin Recent Development
    Table 66. Roche Company Detail
    Table 67. Roche Business Overview
    Table 68. Roche Prostate-specific Antigen (PSA) Testing Product
    Table 69. Roche Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
    Table 70. Roche Recent Development
    Table 71. Beckman Coulter Company Detail
    Table 72. Beckman Coulter Business Overview
    Table 73. Beckman Coulter Prostate-specific Antigen (PSA) Testing Product
    Table 74. Beckman Coulter Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
    Table 75. Beckman Coulter Recent Development
    Table 76. PerkinElmer Company Detail
    Table 77. PerkinElmer Business Overview
    Table 78. PerkinElmer Prostate-specific Antigen (PSA) Testing Product
    Table 79. PerkinElmer Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
    Table 80. PerkinElmer Recent Development
    Table 81. Tosoh Company Detail
    Table 82. Tosoh Business Overview
    Table 83. Tosoh Prostate-specific Antigen (PSA) Testing Product
    Table 84. Tosoh Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
    Table 85. Tosoh Recent Development
    Table 86. Ortho Clinical Company Detail
    Table 87. Ortho Clinical Business Overview
    Table 88. Ortho Clinical Prostate-specific Antigen (PSA) Testing Product
    Table 89. Ortho Clinical Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
    Table 90. Ortho Clinical Recent Development
    Table 91. Fujirebio Company Detail
    Table 92. Fujirebio Business Overview
    Table 93. Fujirebio Prostate-specific Antigen (PSA) TestingProduct
    Table 94. Fujirebio Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
    Table 95. Fujirebio Recent Development
    Table 96. Mediwatch Company Detail
    Table 97. Mediwatch Business Overview
    Table 98. Mediwatch Prostate-specific Antigen (PSA) TestingProduct
    Table 99. Mediwatch Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
    Table 100. Mediwatch Recent Development
    Table 101. BodiTech Company Detail
    Table 102. BodiTech Business Overview
    Table 103. BodiTech Prostate-specific Antigen (PSA) TestingProduct
    Table 104. BodiTech Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
    Table 105. BodiTech Recent Development
    Table 106. Bristol-Myers Squibb Company Company Detail
    Table 107. Bristol-Myers Squibb Company Business Overview
    Table 108. Bristol-Myers Squibb Company Prostate-specific Antigen (PSA) TestingProduct
    Table 109. Bristol-Myers Squibb Company Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
    Table 110. Bristol-Myers Squibb Company Recent Development
    Table 111. GE Healthcare Company Detail
    Table 112. GE Healthcare Business Overview
    Table 113. GE Healthcare Prostate-specific Antigen (PSA) TestingProduct
    Table 114. GE Healthcare Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
    Table 115. GE Healthcare Recent Development
    Table 116. Endocare Company Detail
    Table 117. Endocare Business Overview
    Table 118. Endocare Prostate-specific Antigen (PSA) TestingProduct
    Table 119. Endocare Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
    Table 120. Endocare Recent Development
    Table 121. Merck＆Co. Company Detail
    Table 122. Merck＆Co. Business Overview
    Table 123. Merck＆Co. Prostate-specific Antigen (PSA) TestingProduct
    Table 124. Merck＆Co. Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
    Table 125. Merck＆Co. Recent Development
    Table 126. Medtronic Company Detail
    Table 127. Medtronic Business Overview
    Table 128. Medtronic Prostate-specific Antigen (PSA) TestingProduct
    Table 129. Medtronic Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
    Table 130. Medtronic Recent Development
    Table 131. Sanofi-Aventis SA Company Detail
    Table 132. Sanofi-Aventis SA Business Overview
    Table 133. Sanofi-Aventis SA Prostate-specific Antigen (PSA) TestingProduct
    Table 134. Sanofi-Aventis SA Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
    Table 135. Sanofi-Aventis SA Recent Development
    Table 136. Research Programs/Design for This Report
    Table 137. Key Data Information from Secondary Sources
    Table 138. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Prostate-specific Antigen (PSA) Testing Market Share by Type: 2021 VS 2028
    Figure 2. CLIA Method Features
    Figure 3. ELISA Method Features
    Figure 4. Global Prostate-specific Antigen (PSA) Testing Market Share by Application in 2021 & 2028
    Figure 5. Screening Case Studies
    Figure 6. Post-treatment Monitoring Case Studies
    Figure 7. Other Case Studies
    Figure 8. Prostate-specific Antigen (PSA) Testing Report Years Considered
    Figure 9. Global Prostate-specific Antigen (PSA) Testing Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Prostate-specific Antigen (PSA) Testing Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Prostate-specific Antigen (PSA) Testing Market Share by Region: 2021 VS 2028
    Figure 12. Global Prostate-specific Antigen (PSA) Testing Market Share by Players in 2021
    Figure 13. Global Top Prostate-specific Antigen (PSA) Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate-specific Antigen (PSA) Testing as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Prostate-specific Antigen (PSA) Testing Revenue in 2021
    Figure 15. North America Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 16. North America Prostate-specific Antigen (PSA) Testing Market Share by Country (2017-2028)
    Figure 17. United States Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. Canada Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Europe Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Prostate-specific Antigen (PSA) Testing Market Share by Country (2017-2028)
    Figure 21. Germany Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. France Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. U.K. Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Italy Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Russia Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Nordic Countries Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Share by Region (2017-2028)
    Figure 29. China Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Japan Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. South Korea Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Southeast Asia Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. India Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Australia Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Latin America Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Prostate-specific Antigen (PSA) Testing Market Share by Country (2017-2028)
    Figure 37. Mexico Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Brazil Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Share by Country (2017-2028)
    Figure 41. Turkey Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Saudi Arabia Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Abbott Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
    Figure 44. Boston Scientific Corporation Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
    Figure 45. Bayer AG Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
    Figure 46. Siemens Healthcare Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
    Figure 47. DiaSorin Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
    Figure 48. Roche Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
    Figure 49. Beckman Coulter Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
    Figure 50. PerkinElmer Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
    Figure 51. Tosoh Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
    Figure 52. Ortho Clinical Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
    Figure 53. Fujirebio Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
    Figure 54. Mediwatch Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
    Figure 55. BodiTech Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
    Figure 56. Bristol-Myers Squibb Company Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
    Figure 57. GE Healthcare Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
    Figure 58. Endocare Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
    Figure 59. Merck＆Co. Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
    Figure 60. Medtronic Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
    Figure 61. Sanofi-Aventis SA Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Abbott
Boston Scientific Corporation
Bayer AG
Siemens Healthcare
DiaSorin
Roche
Beckman Coulter
PerkinElmer
Tosoh
Ortho Clinical
Fujirebio
Mediwatch
BodiTech
Bristol-Myers Squibb Company
GE Healthcare
Endocare
Merck＆Co.
Medtronic
Sanofi-Aventis SA
Frequently Asked Questions
Prostate-specific Antigen (PSA) Testing report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Prostate-specific Antigen (PSA) Testing report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Prostate-specific Antigen (PSA) Testing report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports